Shahar Lev-Ari | Medicine and Health Sciences | Best Researcher Award

Published on 16/09/202516/09/2025 by Research Hypothesis

Dr. Shahar Lev-Ari | Medicine and Health Sciences | Best Researcher Award

Visiting Faculty | Stanford University | United States

Dr. Shahar Lev-Ari is an accomplished academic with a strong educational foundation in cellular biology and medicine who has over many years built a distinguished career in health promotion, public health research, integrative medicine, and well-being interventions; Dr. Shahar Lev-Ari was trained in cellular biology and obtained his PhD after rigorous work in integrative medicine and intervention science, and his education included advanced training in health promotion science and mindfulness-based behavior change. In his professional experience, Dr. Shahar Lev-Ari has served as founding director of the Integrative Medicine Center & Laboratory of Medicinal Herbs and Cancer Research at the Institute of Oncology, led the Health Promotion Unit within the Integrated Cancer Prevention Center at Tel Aviv Medical Center, and formerly chaired the Department of Health Promotion, School of Public Health at Tel Aviv University; he is also a visiting scholar in Stanford University’s Department of Genetics and collaborates internationally in precision health and psychosocial interventions. Research interests of Dr. Shahar Lev-Ari focus on mindfulness and stress-reduction techniques, inquiry-based stress reduction (IBSR), salutogenesis, resilience, psychosocial health, mental well-being, interventions in at-risk populations (e.g. women with BRCA variants), longevity and protective behavioral and psychosocial factors, mind-body medicine, and digital health tools for well-being. He has developed skills in both quantitative and intervention research; expertise in randomized clinical trials, longitudinal cohort studies, psychosocial measurement, sleep assessments, behavior change, developing and evaluating interventions, public health promotion, multi-disciplinary collaborators, mixed-methods, psychosocial biometrics, and implementing rigorous designs. Dr. Shahar Lev-Ari has been recognized with awards and honours such as the Outstanding Scientist Award from the Israel Society for Complementary Medicine under the auspices of the Israeli Medical Association, and has received support from organizations such as the Rothschild Foundation, the Israeli Cancer Association, and chief scientists in education and medicine; he has also been invited to serve on editorial boards (e.g., Section Editor for Public Health in Journal of Clinical Medicine), and in national and global working groups on mental health promotion. In his published record, Dr. Shahar Lev-Ari has authored 81 documents, has accumulated 2,106 citations, and has h-index 22, demonstrating both breadth and impact. Overall, Dr. Shahar Lev-Ari embodies a scholar-practitioner who bridges fundamental biology, public health, psychosocial interventions and community health implementation, with leadership roles in research, mentorship, and translation of findings into interventions that improve psychological well-being and health outcomes in both general and vulnerable populations.

Profile: Scopus | ORCID

Featured Publications

Effect of Inquiry-Based Stress Reduction on Well-being and Views on Risk-Reducing Surgery Among Women With BRCA Variants in Israel: A Randomized Clinical Trial — 2021; ~3 citations
The Association Between the Sense of Coherence and the Self-Reported Adherence to Guidelines During the First Months of the COVID-19 Pandemic in Israel — 2022; number of citations
The Use of Smart Devices for Mental Health Diagnosis and Care — 2022; number of citations
A Novel Platform for Attenuating Immune Hyperactivity Using EXO-CD24 in COVID-19 and Beyond — 2022; number of citations
Data From a One-Stop-Shop Comprehensive Cancer Screening Center — 2023; number of citations
Mental Health for All: The Case for Investing in Digital Mental Health to Improve Global Outcomes, Access, and Innovation in Low-Resource Settings — 2023; number of citations

Samuel Zünd | Medicine and Health Sciences | Best Researcher Award

Published on 27/05/202527/05/2025 by Research Hypothesis

Samuel Zünd | Medicine and Health Sciences | Best Researcher Award

Paramedic at Geneva University Hospitals, Switzerland

Mr. Samuel Zünd is a senior paramedic and operational manager with a dynamic career dedicated to emergency medical services and prehospital care. Based in Orbe, Switzerland, Mr. Zünd is known for his organizational excellence, cross-functional leadership, and a deeply rooted passion for collaborative and inclusive healthcare development. With more than two decades of experience in paramedicine, he has contributed to advanced systems of care, multidisciplinary coordination, and the strengthening of educational and research frameworks in Switzerland. Samuel excels in project and case management, particularly in stroke unit coordination and emergency care innovations. Through his leadership roles in prestigious Swiss paramedic institutions and his active involvement in research networks, Mr. Zünd continues to inspire excellence and innovation in the field of prehospital emergency medicine.

Publication Profile

Orcid

Education

While the exact formal education timeline is not listed, Mr. Samuel Zünd has undergone comprehensive paramedic training and educational leadership development, beginning with basic paramedic training (2004–2007). He has since progressed through multiple academic and professional teaching roles, including on-field instruction in paramedic degree programs. His affiliation with renowned institutions such as MEDI – École Supérieure d’Ambulancier et Soins d’Urgence Romande and ESAMB highlights a sustained engagement in advanced education for emergency care professionals. Furthermore, his involvement in research coordination and academic training management reflects not only formal knowledge but also his ability to bridge education with practice and innovation. His multilingual fluency in French, English, and German also underlines a strong academic adaptability in diverse research and professional environments.

Experience

Mr. Zünd’s career trajectory reflects progressive responsibilities in paramedicine and healthcare system leadership. Starting as a basic paramedic (2004–2007), he transitioned into a full paramedic role (2007–2018), where he gained hands-on experience in high-pressure emergency situations. Since 2018, he has served as a senior paramedic and operational manager, leading initiatives that ensure streamlined emergency responses and improved patient outcomes. He holds current roles at SPS Neuchâtel as a training and project management leader, and at the Association Sécurité Riviera coordinating stroke units. His interdisciplinary work with CSU Trois Vallons and leadership in research with the Association for Prehospital Research Promotion (APRP) further demonstrate his commitment to bridging clinical excellence with research innovation. His teaching, project leadership, and coordination of prehospital networks embody a career built on responsibility, innovation, and impact.

Awards and Honors

While specific individual awards are not listed in the provided details, Mr. Samuel Zünd’s leadership roles and project responsibilities speak volumes of the trust and recognition he holds in the Swiss emergency medical field. His appointment as project and training manager in SPS Neuchâtel, and his coordination responsibilities for stroke care systems, highlight his recognized expertise in clinical improvement and system design. Moreover, his presidency role since 2007 and coordination of a national prehospital research network underscore his reputation as a thought leader in the domain. His publication in a peer-reviewed journal, focused on Swiss paramedics’ intention to engage in research (SPECTRe), further substantiates his impact on shaping research culture in emergency care. These roles and accomplishments collectively reflect high professional recognition, research respectability, and a meaningful contribution to Swiss and global healthcare development.

Research Focus

Mr. Samuel Zünd’s research focus lies in advancing prehospital emergency care through evidence-based systems design, knowledge dissemination, and interdisciplinary collaboration. He is particularly interested in enhancing the readiness and effectiveness of emergency medical systems, with a core emphasis on stroke unit coordination and trauma response frameworks. His research work supports the implementation of innovative training models and encourages paramedics to actively participate in scholarly initiatives. Through the Association for Prehospital Research Promotion (APRP), Mr. Zünd has led initiatives to develop networks connecting healthcare professionals with research opportunities, thereby promoting data-driven improvements in field operations. His forward-looking perspective on system-level integration of research into practice reflects a strategic vision to uplift paramedicine standards globally. He aims to inspire and empower frontline responders to embrace research as a means of continual professional development and improved patient outcomes.

Publication Top Notes

Impact of the First Swiss Conference on Prehospital Emergency Care and Trauma Research (SPECTRe) on Paramedics’ Intention to Engage in Research: Cross-sectional Study

Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Published on 26/05/202526/05/2025 by Research Hypothesis

Dr. Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Albina Tummolo at Children Hospital Giovanni XXIII, Italy.

Dr. Albina Tummolo is an accomplished pediatrician specializing in metabolic and genetic disorders. With over two decades of clinical and academic experience, she has built a significant profile in managing and researching rare pediatric diseases. Based at the Policlinico of Bari, she combines patient care with academic research, national coordination roles, and continuous engagement with international advisory boards. Dr. Tummolo is also an active educator, teaching at several Italian universities and training healthcare professionals in hereditary metabolic diseases. Her work has shaped protocols and policies for improved pediatric metabolic care in Italy.

Publication Profile

Orcid

Education

Dr. Albina Tummolo earned her Degree in Medicine and Surgery from the University of Foggia in 2002 and completed her Specialization in Pediatrics (General and Specialist) at the University of Bari in 2007. She holds multiple postgraduate certifications in specialized pediatrics, infectivity, rheumatology, and rare diseases from the University of Bari and the University of Florence. She furthered her academic credentials with an MSc in Clinical Pediatrics from University College London in 2008 and a PhD in Pediatric Sciences from the University of Bari in 2011. In 2023, she completed an MSc in Epidemiology and Biostatistics at Università Cattolica di Roma.

Experience

Dr. Tummolo currently serves as a Senior Pediatrician at the Ospedale Pediatrico “Giovanni XXIII” in Bari, within the Unit of Metabolic and Genetic Diseases, a role she has held since 2015. She has also worked as a senior pediatrician at the Azienda Ospedaliera di Padova and Presidio Ospedaliero “Perrino” dell’ASL di Brindisi. She is a registered physician with the Order of Physicians and Surgeons of Bari (License No. 5742, since September 18, 2003).

Dr. Tummolo has extensive experience leading and participating in clinical trials and observational studies focused on inborn errors of metabolism, lysosomal storage disorders, and rare genetic conditions, often acting as Principal Investigator or Scientific Coordinator. She serves as a member and secretary of national expert committees and advisory boards and contributes to shaping diagnostic and therapeutic strategies for metabolic disorders in Italy and Europe.

Research Focus

Inborn errors of metabolism and rare genetic diseases
Lysosomal storage disorders (including LAL-D, Gaucher disease, and alpha-mannosidosis)
Phenylketonuria (PKU) and organic acidurias
Neonatal screening programs
Epidemiology and real-world evidence in pediatric metabolic disorders
Nutritional and enzyme replacement therapies in pediatric populations

Author Metrics & Scientific Contributions

Principal Investigator in multiple national and international clinical trials
Scientific Member of the Telethon Undiagnosed Diseases Program (TUDP) and E-HOD
Coordinator/Advisor for over 30 expert boards and working groups, including SIMMESN
Co-author of educational and clinical monographs, including:
- “Inherited Metabolic Disorders Neonatal Screening” (2014)
- Educational booklets on MSUD, TYR, HCU, MMA/PA, GA, IVA, and PKU (2020–2022)
- Springer Healthcare Monography (2025) on velmanase alfa treatment in alpha-mannosidosis

She has contributed substantially to national consensus statements, educational masterclasses, and international forums on metabolic disease management.

Publication Top Notes

1. Exploring Partners, Parenting and Pregnancy Thinking in Late Adolescents and Young Adults with Inherited Metabolic Disorders

📅 Pediatric Reports, May 2025
🔗 DOI: 10.3390/pediatric17030056
👩‍🔬 Contributors: Albina Tummolo, Giulia Paterno, Rosa Carella, Livio Melpignano, Donatella De Giovanni
Focus: Examines reproductive health perspectives in adolescents and young adults affected by inherited metabolic disorders.

2. Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?

📅 Pediatric Reports, October 2024
🔗 DOI: 10.3390/pediatric16040076
👩‍🔬 Contributors: Giulia Paterno, Vito Di Tullio, Rosa Carella, Giada De Ruvo, Fabrizio Furioso, Aleksandra Skublewska-D’Elia, Donatella De Giovanni, Albina Tummolo
Focus: Investigates obesity prevalence among patients with phenylketonuria (PKU) versus healthy peers.

3. Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients

📅 Nutrients, February 2024
🔗 DOI: 10.3390/nu16050669
👩‍🔬 Contributors: Albina Tummolo, Rossella Carella, Pasquale Carone, Giulia Paterno, Donatella De Giovanni
Focus: Real-world insights into how PKU patients consume amino acid supplements.

4. CHAMP1-related Disorders: Pathomechanisms Triggered by Different Genomic Alterations Define Distinct Nosological Categories

📅 European Journal of Human Genetics, 2023
🔗 DOI: 10.1038/S41431-023-01305-Z
🔍 WOSUID: WOS:000939855800002
👩‍🔬 Contributors: Amenta S., Marangi G., Orteschi D., Frangella S., Gurrieri F., Paccagnella E., Scala M., Romano F., Capra V., Nigro V., et al.
Focus: Differentiates clinical categories of CHAMP1-related disorders based on genomic mechanisms.

5. Long-term Safety and Efficacy of Velmanase Alfa Treatment in Children Under 6 Years of Age with Alpha-Mannosidosis: A Phase 2, Open Label, Multicenter Study

📅 Journal of Inherited Metabolic Disease, 2023
🔗 DOI: 10.1002/JIMD.12602
🔍 WOSUID: WOS:000948401000001
👩‍🔬 Contributors: Guffon N., Konstantopoulou V., Hennermann J.B., Muschol N., Bruno I., Tummolo A., Ceravolo F., Zardi G., Ballabeni A., Lund A.
Focus: Evaluates velmanase alfa’s therapeutic profile in pediatric alpha-mannosidosis patients.

Conclusion

Dr. Albina Tummolo exemplifies the core values of the Best Researcher Award in Medicine and Health Sciences through her compassion-driven pediatric care, trailblazing research, and influence on national health systems. Her unique blend of clinical depth, academic rigor, and policy impact makes her an ideal candidate for this recognition.

She not only advances medical science but also improves the lives of children with rare diseases—one diagnosis, one protocol, and one family at a time.

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Published on 03/05/202503/05/2025 by Research Hypothesis

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Prof Jim Sheu, National Sun Yatsen University, Taiwan

Prof. Jim Sheu is a distinguished biomedical scientist with over two decades of academic and research excellence in life sciences. Holding a Ph.D. in Life Science from National Tsing-Hua University (2002), he has consistently advanced the frontiers of molecular oncology, stem cell therapy, and women’s reproductive health. Currently a professor at National Sun Yat-sen University, Taiwan, he has previously held prestigious research and academic positions at China Medical University and Johns Hopkins Medical Institutions. He is widely recognized for his role in leading innovative biomedical projects and mentoring the next generation of scientists. Prof. Sheu has made pioneering contributions to cancer genomics, glioblastoma therapeutics, and endometriosis research. His prolific publication record and multiple awards underline his leadership and innovation in the field. His work bridges translational research with clinical applications, shaping modern therapeutic strategies.

Publication Profile

Google Scholar

Education

Prof. Jim Sheu’s educational journey laid a strong foundation for his impactful scientific career. He earned his Ph.D. in Life Science from the prestigious National Tsing-Hua University, Taiwan, in 2002 🧬. This doctoral training provided him with deep expertise in molecular biology, genetics, and biomedical research. Prior to that, he completed his B.S. in Biology from Fu-Jen University, Taiwan, in 1994 🧪. The rigorous academic environment at these institutions honed his critical thinking and experimental skills. His thesis and postdoctoral work involved advanced molecular techniques and translational research applications. With education deeply rooted in cellular biology and medical biotechnology, Prof. Sheu has seamlessly integrated his academic background with real-world research, evolving into a leading expert in cancer biology, stem cell therapies, and women’s health. His academic excellence has continued to inspire his students and collaborators across various institutes.

Experience

Prof. Sheu’s career spans academia, clinical research, and biotechnology. Since 2014, he has served as Professor at the Institute of Biomedical Sciences, National Sun Yat-sen University 🏫. Previously, he held multiple roles at China Medical University (2006–2014), including Researcher, Professor, Associate Professor, and Assistant Professor in the Graduate Institute of Chinese Medical Science 🧑‍🏫. His early international experience includes being a Research Fellow at Johns Hopkins Medical Institutions (2004–2006) 🔬. He also held leadership positions at Taiwan’s Development Center for Biotechnology (2003–2004), directing and managing key protein drug and biomedicine projects. His academic and research trajectory is marked by interdisciplinary innovation, integrating biomedical engineering, genetics, and pharmacology. Prof. Sheu’s deep involvement in translational research and collaborative initiatives underpins his reputation as a scientific leader in Taiwan and beyond.

Awards & Honors

Prof. Sheu has earned several prestigious honors celebrating his research excellence and innovation. In 2023, he was part of the award-winning Biomedical Team at National Sun Yat-sen University for a serum-free stem cell medium at the NBRP Pitch Day 🧫🏅. He also received the Outstanding Faculty of Basic Research award and the Tien-Te Lee Award for an outstanding poster on stem cell therapies for Parkinson’s disease. In 2022, he was honored by the Taiwan Endometriosis Society for his research using traditional medicine to modulate immune responses 🌿🧠. Additionally, he won the Prof. Chii-Ruey Tzeng Award for an impactful paper in endometriosis research. These accolades highlight Prof. Sheu’s interdisciplinary impact, bridging traditional Chinese medicine, molecular biology, and cutting-edge therapeutic development. His continuous recognition by scientific communities underscores his leadership in biomedical innovation.

Research Projects

Prof. Jim Sheu has actively contributed as a project reviewer in the field of life sciences since 2012 🌱. He serves the National Science and Technology Council (NSTC) in Taiwan and has reviewed projects for various institutions including Tri-Service General Hospital (2021–present), Kaohsiung Veterans General Hospital (2021–present), and Zuoying Armed Forces General Hospital (2020–present) 🏥. He also evaluated projects for National Tsing-Hua University (2023) and Kaohsiung Chang Gung Smart Hospital (2022) 🎓. His expertise has extended globally, reviewing for Italy’s Ministry of Health in 2015 🇮🇹 and South Africa’s Medical Research Council in 2012 🇿🇦, showcasing his international recognition 🌍.

Research Focus

Prof. Sheu’s research is centered on cancer biology, stem cell therapy, gynecological diseases, and translational medicine. He explores the molecular mechanisms of tumor progression, particularly in microsatellite instability and glioblastoma 🔍🧠. His investigations into ethnic-specific genetic markers for endometriosis and ovarian aging highlight his commitment to personalized medicine. Another focus lies in the regulation of immune responses using traditional herbal compounds, bridging modern molecular science with Eastern medicine 🌿🧪. He has led multi-omics studies that decode complex disease pathways, including mitochondrial dysfunction in breast cancer. Additionally, he is advancing serum-free stem cell enhancement technologies aimed at clinical application. Prof. Sheu’s interdisciplinary approach links genomics, proteomics, and pharmacology, translating basic research into viable therapeutic strategies. His work significantly contributes to understanding cellular aging, reproductive biology, and cancer therapy.

Publication Top Notes

Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells

Autophagy and its link to type II diabetes mellitus

Talin‐1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis

Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Published on 22/04/202522/04/2025 by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Published on 07/03/202507/03/2025 by Research Hypothesis

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Dr VIVEKANAND ASHOK, Azeezia Health City, India

Dr. Vivekanand Ashok is a dedicated otorhinolaryngologist with a passion for research and surgical excellence. His extensive work spans cochlear implants, otologic surgeries, and head and neck disorders. With numerous high-impact publications in esteemed journals, his research has significantly contributed to advancements in ENT care. His clinical expertise in endoscopic sinus surgery, thyroid disorders, and voice disorders, combined with his academic contributions, makes him a deserving candidate for the Best Researcher Award. His continuous pursuit of innovation in ENT treatments, active participation in conferences, and commitment to medical education further solidify his reputation as an outstanding researcher. 🏅📚🔬

Publication Profile

Orcid

Education

Dr. Vivekanand Ashok 🎓 pursued his MBBS from Azezia Institute of Medical Sciences, Kerala (2014) 🏥📖, followed by an M.S in ENT from Bangalore Medical College and Research Institute, Karnataka (2020) 🎓🩺. He further obtained a DNB (ENT) in 2021 🏅📚 and completed a Fellowship in Cochlear Implant Surgery at GMERS Gandhinagar in 2023 🎧🔬. With a strong foundation in otorhinolaryngology, he specializes in ENT surgeries and cochlear implants, demonstrating his dedication to patient care. His rigorous training at top institutions has equipped him with expertise in handling complex ENT cases, establishing him as a leader in the field. 📘💉🔍

Experience

Dr. Vivekanand Ashok is a distinguished ENT specialist with extensive experience in medical education, clinical practice, and research. He served as a Senior Resident at Karnataka Institute of Medical Sciences (2020-2021) 🏨👨‍⚕️ and Malabar Cancer Centre, Kerala (2021-2022) 🎗️🏥, honing his expertise in otolaryngology. Transitioning into academia, he worked as an Assistant Professor at Karuna Medical College, Kerala (2022-2024) 🎓📖, shaping future medical professionals. Currently, he excels as a Senior Consultant at Co-operative Hospital, Kattappana (2024-2025) 🏨🩺 and Azeezia Health City, Palakkad (2025-Present) ⚕️🔬. His dedication to patient care and surgical excellence makes him a respected figure in the field. 🏆👨‍⚕️

Awards & Honors

Dr. Vivekanand Ashok’s dedication to academic excellence and research has earned him prestigious accolades in the field of ENT. He secured 3rd position in the South Zone ENT Quiz (2018) 🥉🧠, demonstrating his deep knowledge and expertise. In 2019, he was a Zonal Round Participant in the South Zone Young Scholar Award 🎖️📖, further highlighting his commitment to continuous learning and professional growth. These achievements reflect his passion for advancing medical knowledge and contributing to the field of otolaryngology. Through his dedication to research and education, Dr. Ashok continues to make a significant impact in the medical community. 🏆🔬

Research Focus

Dr. Ashok specializes in otorhinolaryngology, cochlear implants, head and neck surgery, and otologic diseases. His research focuses on laryngopharyngeal reflux, rhino-orbital mucormycosis, thyroid carcinomas, and nasal hemangiomas. His work has contributed to improving diagnostic techniques and treatment approaches in ENT disorders. With a passion for innovation, he continues to explore advancements in hearing restoration, sinus surgery, and minimally invasive ENT procedures. 🎧👂📊